H.B. Fuller Reports Strong Q2 2026 Results; Raises Full-Year Guidance
H.B. Fuller delivered strong second quarter fiscal 2026 results with net revenue of $950.271 million (+5.81% YoY), adjusted EPS of $1.41 (+19% YoY) beating consensus, and record Q2 operating cash flow of $121 million. The company raised its FY2026 adjusted EPS guidance to $4.60–$4.90 and adjusted EBITDA guidance to $650 million–$675 million, reflecting confidence in continued execution amid a dynamic external environment.

*this image is generated using AI for illustrative purposes only.
H.B. Fuller Company reported second quarter fiscal 2026 financial results for the period ended May 30, 2026, delivering strong year-on-year growth across revenue, earnings, and cash flow. The world's largest pure-play adhesives company posted net revenue of $950.271 million, surpassing the analyst consensus estimate of $924.792 million and representing a 5.81% increase over $898.095 million in the prior year period. Adjusted earnings per share (diluted) came in at $1.41, up 19% year-on-year and ahead of the analyst consensus estimate of $1.40. Reported EPS (diluted) was $1.23. The company also achieved record second quarter operating cash flow of $121 million, up approximately 10% year-on-year.
Key Second Quarter Financial Highlights
The following table summarizes H.B. Fuller's key financial metrics for the second quarter:
| Metric: | Q2 FY2026 | Q2 FY2025 | Change (%) |
|---|---|---|---|
| Net Revenue: | $950.271 million | $898.095 million | +5.81% |
| Gross Profit: | $319.654 million | $286.384 million | — |
| Gross Margin: | 33.6% | 31.9% | +170 bps |
| Adjusted Gross Margin: | 34.2% | 32.2% | +200 bps |
| Net Income (attributable to H.B. Fuller): | $67.805 million | $41.828 million | — |
| Adjusted Net Income: | $77.532 million | $64.652 million | — |
| Adjusted EBITDA: | $181.045 million | $165.660 million | +9% |
| Adjusted EBITDA Margin: | 19.1% | 18.4% | +70 bps |
| Reported EPS (diluted): | $1.23 | $0.76 | — |
| Adjusted EPS (diluted): | $1.41 | $1.18 | +19% |
| Operating Cash Flow: | $121 million | — | ~+10% |
Organic revenue increased 2.6% year-on-year, driven by a 3.0% pricing increase that more than offset slightly lower volume of (0.4)%. Foreign currency translation and acquisitions contributed 3.1% and 0.1% to net revenue growth, respectively. Selling, general and administrative (SG&A) expense was $202.365 million, with adjusted SG&A of $196.498 million, up 11% year-on-year. Adjusted SG&A, excluding foreign exchange and variable compensation impacts, was up approximately 3% year-on-year.
Segment Performance
H.B. Fuller operates through three segments. The table below presents segment net revenue and adjusted EBITDA for the second quarter:
| Segment: | Q2 2026 Revenue | Q2 2025 Revenue | Q2 2026 Adj. EBITDA | Q2 2025 Adj. EBITDA | Q2 2026 Adj. EBITDA Margin |
|---|---|---|---|---|---|
| Hygiene, Health and Consumable Adhesives: | $421.861 million | $397.475 million | $75.564 million | $61.963 million | 17.9% |
| Engineering Adhesives: | $283.239 million | $276.418 million | $63.544 million | $63.341 million | 22.4% |
| Building Adhesive Solutions: | $245.171 million | $224.202 million | $41.414 million | $37.535 million | 16.9% |
Balance Sheet and Working Capital
Net debt at the end of the second quarter of fiscal 2026 was $1,958 million, down $58 million year-on-year. Net debt-to-adjusted EBITDA stood at 3.1X, an improvement from 3.4X at the end of the second quarter of fiscal 2025. Net working capital as a percentage of annualized net revenue was 16.4%, a sequential decrease of 260 basis points versus the first quarter. Total assets as of May 30, 2026 were $5,328.793 million, compared to $5,182.706 million as of November 29, 2025.
Management Commentary
Celeste Mastin, president and chief executive officer, commented: "We executed very well in the second quarter, delivering strong year-on-year revenue, EBITDA, and EPS growth, with results above the midpoint of our EBITDA guidance range. Our global sourcing capabilities and swift pricing actions have enabled us to maintain supply continuity and reliably serve our customers through market disruption. These efforts, combined with our Quantum Leap restructuring initiative, have strengthened our competitive position and we remain confident in our ability to deliver strong financial results."
Mastin added: "While the external environment remains dynamic, our focus is clear: we are executing on what we can control, leveraging our competitive strengths, and continuing to build a business that is more durable and better positioned to deliver superior long-term growth."
Fiscal 2026 Guidance
Based on year-to-date performance, H.B. Fuller raised the midpoint of its full-year adjusted EBITDA and adjusted EPS guidance. The updated fiscal 2026 outlook is summarized below:
| Guidance Metric: | Updated FY2026 Outlook |
|---|---|
| Net Revenue Growth: | Up mid-single digits |
| Organic Revenue Growth: | Up low-single digits |
| Foreign Exchange Impact: | Positive 1% to 2% |
| Adjusted EBITDA: | $650 million to $675 million |
| Adjusted EPS (diluted): | $4.60 to $4.90 |
| Cash Flow from Operations: | $300 million to $325 million |
| Q3 2026 Net Revenue Growth: | Up mid-single digits |
| Q3 2026 Adjusted EBITDA: | $180 million to $190 million |
The updated adjusted EPS guidance range of $4.60–$4.90 compares to the analyst consensus estimate of $4.84 and the previously communicated range of $4.55–$4.90. On April 16, H.B. Fuller also increased its quarterly dividend by 4.3%.
Analyst Ratings and Price Targets
Several Wall Street analysts have recently revised their outlooks on the stock. The table below summarizes recent analyst actions:
| Firm: | Analyst: | Rating: | Price Target: | Accuracy: |
|---|---|---|---|---|
| UBS: | Lucas Beaumont | Neutral | $71 | — |
| JP Morgan: | Jeffrey Zekauskas | Neutral | $58 | 64% |
| Citigroup: | Patrick Cunningham | Buy | $70 | 62% |
| Seaport Global: | Michael Harrison | Buy | $80 | 67% |
| Baird: | Ghansham Panjabi | Outperform | $75 | 77% |
UBS analyst Lucas Beaumont maintained a Neutral rating while raising the price target to $71 from $63. JP Morgan analyst Jeffrey Zekauskas upgraded the stock from Underweight to Neutral with a price target of $58 on May 27, 2026. Citigroup analyst Patrick Cunningham maintained a Buy rating and raised the price target from $67 to $70 on March 30, 2026. Seaport Global analyst Michael Harrison upgraded the stock from Neutral to Buy with a price target of $80 on Sept. 26, 2025. Baird analyst Ghansham Panjabi maintained an Outperform rating and boosted the price target from $60 to $75 on June 27, 2025.
How will the company balance the 3% pricing increases against potential volume declines if macroeconomic demand softens in the second half of the fiscal year?
What specific impact is the Quantum Leap restructuring initiative expected to have on margin expansion and cost savings going forward?
With net debt-to-adjusted EBITDA improving to 3.1X, will H.B. Fuller prioritize further debt reduction or increase shareholder returns through dividends and buybacks?


























